tetramethylarsonium has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
*Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creus, A; Fortaner, S; Guillamet, E; Marcos, R; Ponti, J; Sabbioni, E | 1 |
1 other study(ies) available for tetramethylarsonium and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay.
Topics: Arsenates; Arsenicals; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2004 |